Intermittent negative pressure therapy in patients with no-option chronic limb-threatening ischemia
Vasa · 2023
DOI: 10.1024/0301-1526/a001098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vasa, 2023. Verfasst von Shatlyk Yagshyyev und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany. Hauptthemen laut MEDLINE: Chronic Limb-Threatening Ischemia, Lower Extremity. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Aim of this study was to assess the influence of intermitted negative pressure (INP) therapy on the foot microcirculation in patients with no-option CLTI. Patients and methods: CLTI patients defined as no option for revascularization on the basis of an interdisciplinary vascular board decision (interventional radiology, vascular surgery) were included in this study. INP therapy was performed at home. Therapy regime was: 1 hour twice daily. Follow-up was after 6 weeks and 3 months. Microcirculation measurement was performed by laser Doppler flowmetry and white light spectrometry (oxygen to see, O2C TM ). Following parameters were evaluated: oxygen saturation (sO2 in%), relative hemoglobin (rHb) and flow (in arbitrary units A.U.). Additionally the clinical outcome of the patients was assessed.
Results
From September 2020 to June 2022, 228 patients were screened. In total 19 patients (13 men, 6 women, mean age was 73.95 years) were included. 6 weeks after INP therapy the microcirculation showed a significant improvement for the parameter sO2 (%) (p=0.004). After 3 months a non-significant decrease compared to 6 weeks follow-up was seen for the parameter sO2; however, the perfusion was still improved compared to baseline measurement. With regard to the microperfusion values flow (AU) and hemoglobin (AU), the changes were not significant. Clinically, the patients reported a significant reduction of rest pain after therapy (p=0.005).
Conclusions
INP therapy in no-option CLTI patients showed a significant improvement of the skin perfusion after 6 weeks. Therefore, INP therapy might have therapeutic potential in these critical ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany.
- Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
ORCID-Profile: Yi Li, Katharina Zetzmann, Veronika Almasi-Sperling, Andreas L H Gerken, Werner Lang
Zitieren
APA
Yagshyyev, S., Hausmann, P., Li, Y., Kempf, J., Zetzmann, K., Dessi, K., Moosmann, O., Almasi-Sperling, V., Meyer, A., Gerken, A. L. H., Lang, W., & Rother, U. (2023). Intermittent negative pressure therapy in patients with no-option chronic limb-threatening ischemia. Vasa. https://doi.org/10.1024/0301-1526/a001098
Vancouver
Yagshyyev S, Hausmann P, Li Y, Kempf J, Zetzmann K, Dessi K, et al. Intermittent negative pressure therapy in patients with no-option chronic limb-threatening ischemia. Vasa. 2023. doi:10.1024/0301-1526/a001098
BibTeX
@article{Yagshyyev2023,
author = {Yagshyyev, Shatlyk and Hausmann, Phillip and Li, Yi and Kempf, Julius and Zetzmann, Katharina and Dessi, Katia and Moosmann, Oxana and Almasi-Sperling, Veronika and Meyer, Alexander and Gerken, Andreas L H and Lang, Werner and Rother, Ulrich},
title = {Intermittent negative pressure therapy in patients with no-option chronic limb-threatening ischemia},
journal = {Vasa},
year = {2023},
doi = {10.1024/0301-1526/a001098}
}
EUVIMED